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Abstract
Assessing the impact that research evidence has on policy is complex. It involves consideration of conceptual
issues of what determines research impact and policy change. There are also a range of methodological issues
relating to the question of attribution and the counter-factual. The dynamics of SRH, HIV and AIDS, like many
policy arenas, are partly generic and partly issue- and context-specific. Against this background, this article reviews
some of the main conceptualisations of research impact on policy, including generic determinants of research
impact identified across a range of settings, as well as the specificities of SRH in particular. We find that there is
scope for greater cross-fertilisation of concepts, models and experiences between public health researchers and
political scientists working in international development and research impact evaluation. We identify aspects of the
policy landscape and drivers of policy change commonly occurring across multiple sectors and studies to create a
framework that researchers can use to examine the influences on research uptake in specific settings, in order to
guide attempts to ensure uptake of their findings. This framework has the advantage that distinguishes between
pre-existing factors influencing uptake and the ways in which researchers can actively influence the policy
landscape and promote research uptake through their policy engagement actions and strategies. We apply this
framework to examples from the case study papers in this supplement, with specific discussion about the
dynamics of SRH policy processes in resource poor contexts. We conclude by highlighting the need for continued
multi-sectoral work on understanding and measuring research uptake and for prospective approaches to receive
greater attention from policy analysts.
Introduction
This paper reviews existing literature to address the fol-
lowing two questions: What are the factors that typically
influence the impact of public health research evidence
on policy? And what are the specificities of research
impact on policy in Sexual and Reproductive Health
(SRH) policy in particular? Throughout this paper we
use the term SRH to encompass HIV and AIDS, as well
as other SRH issues such as sexuality, reproductive ser-
vices and Sexually Transmitted Infection (STI)
treatment.
During recent years, international public health
researchers have been increasing their use of conceptual
analysis, policy theory and policy analysis techniques in
an effort to better understand health policy processes
[1-4]. There have also been numerous calls for policy
and decision makers to increase their uptake and use of
research evidence and systematic reviews, with tools and
models proposed to help guide these decision makers
(see for instance the special issue of Implementation
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this work is informed by concerns with ‘evidence-based
policy’ more broadly in the field of social/public policy
[6,7]. Finally, some efforts have been made in the inter-
national development community to develop models
and frameworks that help explain the uptake of evidence
into policy in low and middle income countries [6]. Of
course, public advocacy groups may also at times call
for greater use of evidence by policy makers, and indeed,
governments’ stated commitment to the use of evidence
may often follow from perceptions of public concerns.
From the bodies of literature engaging with these
issues, there is enormous scope for greater cross-fertili-
sation of concepts in order to provide guidelines and
recommendations to researchers in low and middle
income countries. There is also a great deal of insight to
be provided by the field of policy analysis – as u bf i e l d
of political science dedicated to understanding the pro-
cess of policy change and the factors influencing such
change [8-10]. As most policy analysis work emphasises,
context is particularly important to understanding policy
change, and as such these guidelines must take into
account the specificities of not only the local policy
environment, but also the specifics of the research issue
at hand.
Many researchers and communications specialists
working on SRH have an interest in understanding the
role of research evidence in SRH policy processes, but
often lack knowledge of skills and approaches for ana-
lysing its impact [11]. While in many cases they are
engaging with policy processes throughout their work
and have considerable experiential knowledge of their
specific situations, such individuals often have limited
knowledge of the concepts, skills and frameworks
needed for analysing their experiences and relating them
to other case studies. This paper represents one such
collaboration. Drawing together a team of authors from
various disciplines and backgrounds, it combines
approaches and insights from studies of research impact
involving a range of sectors and settings in order to
examine the challenge of improving and assessing the
uptake of research in SRH policy.
It is not the intention of this article to provide a sys-
tematic review of the entire research impact on policy
literature (that has been more comprehensively
attempted by, among others, Boaz and colleagues [12]).
Rather, we aim to introduce the papers in this special
issue by providing an overview of the conceptual and
empirical issues in the research impact literature with
specific regard to public health, cognizant of the specific
issues raised by SRH policy in particular. Further, we
wish to provide professionals working in public health
with an analytical framework for understanding the fac-
tors influencing research uptake, distinguishing between
those factors related to the context where researchers
are working and the actions that researchers themselves
can take to increase impact. We apply this framework
to the case study papers in this supplement and discuss
the specificities of research impact on policy in the area
of SRH.
It is clear that the impact of research evidence on pol-
i c ya n dp r a c t i c ei sa na g e n d at h a th a sb e e ng a t h e r i n g
momentum. This agenda represents a coming together
of three divergent concerns. The first, from the funders
of research, draws on results-based management and is
concerned with getting value-for-money from research
spending. The second, more typical of those in the
development studies research community, is concerned
with whether research in the area is ‘making a differ-
ence’. Among development researchers there is also
often a normative basis – addressing global poverty and
inequality, and catalysing change. The third, however,
comes from policy makers who may often express frus-
tration about, amongst other things: the seemingly over-
theoretical nature of much research work; the tendency
for researchers to simply appear out of nowhere with
results in hand, hoping or assuming they will be taken
up; and the often limited suggestions for implementa-
tion or operationalisation of issues of relevance.
It is also worth pointing out that ‘researchers’ are not
the only group interested in research uptake and evi-
dence-based policy making. Such guidelines and recom-
mendations may also be of use to lobbyists, advocates
and even potential policy beneficiaries. For example, at
the Paulo Longo Research Initiative (PRLO), sex work-
ers, alongside scholars and policy analysts, are demand-
ing an improved evidence base and more attuned policy
process in order to improve their health and wellbeing.
The appeal of strengthened analytical work on research
uptake and impact is therefore not limited to the formal
researcher community.
In our paper, we focus specifically on evidence arising
from organised research efforts (these can be theoretical,
operational, or evaluative research efforts). Evidence can
take many forms, and have multiple meanings, however.
We recognise the debates around the contested nature
of evidence, and the insights provided by authors such
as Berridge and Stanton [13] who have shown the his-
torical and social construction of ‘evidence based policy’,
as well as authors such as Lin [14] who have illustrated
that policy makers respond to multiple competing prio-
rities to make decisions, not only considering evidence
arising from scientific research. This understanding of
the multitude of evidences from the perspective of the
decision maker is a critical concept to include in policy
analyses. However, the public health field has a much
more established hierarchy of evidence types – with sys-
tematic reviews of randomised trials featuring at the top
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towards the bottom. Policy makers may not share or use
this categorisation of evidence – indeed a common
trend in policy speeches is to invoke specific anecdotes
or cases to sway an audience. But this paper is written
for a public health community concerned with getting
types of evidence deemed to be better quality, and
methodologically robust, into policy and practice. We
therefore accept a positivist bias in our approach to evi-
dence here, primarily because of the audience we target.
This does not mean we ignore the alternative views of
evidence – indeed, an awareness of these alternative
types of evidence is critical for understanding how
research evidence is used – but it means when we speak
of research evidence here, we refer to that which the
public health community has agreed on as valid to act
upon.
The dynamics of SRH – like many policy arenas – are
partly generic and partly issue and context specific. As
with other health-related issues, evidence typically seen
to have policy relevance comes from well established
fields of medicine, epidemiology, and public health.
There are also often established structures or policy
influencing institutions in place to which research find-
ings must be targeted. In many cases, then, promoting
the uptake of evidence into policy may mean identifying
the correct institutions, structures, networks and indivi-
duals with whom to link in order to ensure considera-
tion. However, policy issues relating to SRH can also be
highly politicised and sensitive, requiring a range of
additional approaches or partnerships more explicitly
addressing the political nature of decision making in
order to ensure research engagement. Historically there
have been shifts in global prioritising of different SRH
issues, and the priority placed on SRH issues on the pol-
icy agenda may vary across settings. In many contexts,
past concerns with reproductive health have fallen in
attention, with many sexual and reproductive health
issues conceptualised by policy makers and practitioners
as low priority and low profile. Meanwhile, HIV and
AIDS, originally highly stigmatised and avoided by many
policy makers, has risen up national and international
policy agendas in recent years to attract unprecedented
levels of financial support. Furthermore, priorities may
vary not just between broad SRH categories as just men-
tioned, but also within them. For example, in the Middle
East and North Africa (MENA) region there are a num-
ber of areas of HIV work that remain highly politically
unpalatable, such as the vulnerability of men who have
sex with men. These levels of political prioritisation at
particular points in time set the context in which deci-
sion making on SRH issues is made. It is therefore
necessary to recognise that across the whole health sec-
tor, the political economy of health financing and
management cannot be ignored and may present chal-
lenges to the use of research in policy.
The paper is structured as follows. Section 2 provides
an overview of the conceptual issues in research impact
and policy change with a focus on the health sector.
Section 3 introduces an analytical framework for factors
shaping research impact on policy (presented in Table
1). Section 4 focuses on the specificities of SRH and
applies this analytical framework to the case study
papers in this supplement (see Additional file 1). Section
5 concludes.
The conceptualisation of research impact and policy
change
Studying the impact of research on policy requires con-
ceptualising outcome measures – including the nature
of research ‘impact’ and policy change – as well as
understanding the determinants of policy change itself.
In terms of the research impact on policy, Davies and
colleagues explain:
Non-academic research impact is about identifying the
influences of research findings on policy, managerial
and professional practices, social behaviour or public
discourse. Such impact may be instrumental, influencing
changes in policy, practices and behaviour, or concep-
tual, changing people’s knowledge, understanding and
attitudes towards social issues…research can contribute
not just to decisional choices, but also to the formation
of values, the creation of new understandings and possi-
bilities, and to the quality of public and professional dis-
course and debate [15].
Instrumental and conceptual uses may be intricately
entwined in policy processes. An example from SRH
might be how changing attitudes to specific sub-popula-
tions, such as sex workers or young people, could affect
how health services are designed and targeted, which in
turn may affect the behaviour and practice of health
workers.
Jones and Sumner [16] explore the different ways
research may have an impact on various aspects of pol-
icy and policy processes. These are through:
▪ Agenda setting – changes in policy makers’ priorities
and attention to new or previously under-emphasized
policy issues (for example, following research showing
the growing size of urban versus rural population, grow-
ing urban poverty and lack of reproductive health ser-
vices among the urban poor, the Gates Foundation has
made a sizable investment in implementation research
to demonstrate ways of improving such services), and
shifts in policy framing – changes in the way that policy
makers understand a problem or the possible responses
to it (for example, efforts by NGOs to ‘reframe’ repro-
ductive rights to increase their acceptance and legiti-
macy among policy makers [17]).
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change in the content of policy and/or resources allo-
cated (for example, the introduction of ARVs in HIV
treatment guidelines in developing countries) [18,19].
▪ Changes in the way policy is delivered – substantive
change in the way policy is implemented and/or the way
policy is delivered to intended recipients (for example,
research on the need for greater donor coordination or
increased voice for service users may influence the ways
in which decisions are made in the health sector). Some-
times new health evidence can impact on practice first
and later become integrated into policy, as with the
adoption of new drugs to treat STIs by doctors before a
change in national STI treatment policy [20,21].
In practice these policy impacts may overlap too. For
example, research which leads to the abolition of a parti-
cular ‘failing’ programme could be conceptualised as both
a change in policy content and in policy implementation.
With an understanding of the kinds of impacts
research may have on policy, it is then necessary to
examine the factors that influence policy change.
Research relating to decision-making in public policy
processes in general has evolved from Northern contexts
since Lasswell and Lerner [22], and particularly so in the
1970s/1980s [10,23-27]. Such research has been
expanded to Southern contexts over the last two dec-
ades [1,28-35].
The net result is that there is now a bewildering array
of theories and analytical frameworks that attempt to
describe policy processes or explain factors influencing
policy change (of which research will be only one ele-
ment). In terms of health policy analysis specifically,
there is a rich literature on policy processes which is
broadly consistent with policy studies from other fields.
Walt and Gilson’s classic work on the subject empha-
sises the importance of considering context, processes,
Table 1 An analytical framework for factors shaping research impact on policy
What
determines
policy
outcomes?
Factors shaping research impact on policy
‘Pre-conditions’ affecting research impact on policy Actions and strategies to increase probability of research
impact on policy
Policy ideas,
narratives and
discourse(s)
Extent to which there is a consensus on the nature of the
problem and appropriate responses
Packaging of research or ‘knowledge translation’ for policy
audience – e.g. explicit and clear policy recommendations; short
summaries or briefs; using policy ‘language’ such as economic
vocabulary, framing of research to resonate with prevailing
policy discourses, or tailoring messages to specific policy
environments.
Extent of influence of international discourses on domestic
policy
Research methodologies that develop research user ‘ownership’
throughout the research process.
Extent to which policy issue is novel Explicit, targeted communication and dissemination strategies.
Policy actors and
networks
Extent to which ruling party is ideologically driven Interpersonal relationships and networks - Building or
connecting to policy networks; policy ‘champions’ and
intermediaries and consultations with key policy actors on
research during project.
Extent of ‘special interests’ or range of actors - such as service
users, the private sector, unions, or professional associations; or
strength of civil society, or influence of donors in policy arena.
Credibility or ‘brand’ of the originating institution, funder or
researcher(s).
Level of bureaucracy, professionalism and capacity to process
evidence.
Extent of ‘border-crossing’ between research and policy
communities
Importance placed on systematic and other evidence reviews
by policy makers in power *
Utilising knowledge brokers to specifically get research to policy
makers
Context and
institutions
Extent of democratic openness; degree of academic and
media freedom; norms on consultation and participation in
policy processes.
Planning research to align to specific timing of expected ‘policy
windows’–e.g. research aimed at important meetings of
officials/politicians.
Use of multi-year development plans and other planning
instruments
Planning research to align to ready existing or created ‘policy
spaces’–electoral spaces; consultative spaces; popular protest
spaces, etc.
Level of centralisation of political decision making Framing of research around unexpected events – e.g. the
financial crisis; need for public expenditure efficiency, etc.
Established institutional structures and policy advisory bodies
which exist to link researchers and policy makers*
Working creatively with these structures throughout the research
cycle
Source: Adapted from [16,45,48].
* See [5,49,50].
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tent change [1]. More recent works have built on this to
go further into the importance of actor networks, power
and interests, and multiple conceptualisations of the
policy process – from a simple staged model to one
drawing on Paul Sabatier’sa n dC h r i s t o p h e rW e i b l e ’s
‘advocacy coalitions framework’ which sees the process
of policy change reflecting an ongoing struggle between
opposed groups [2,36-39].
The field of health policy studies has also attempted to
grapple specifically with issues of the use of evidence in
policy. Innvaer and colleagues conducted a review of
studies on health policy-makers’ views of evidence-
usage, identifying 24 studies which had conducted inter-
views with health policy makers [40]. 21 of the 24 stu-
dies examined the role of evidence in actual decision-
making processes, whilst the remaining 3 examined
hypothetical questions. Only 4 of the 24 studies were
conducted in low and middle-income countries (Paki-
stan, Burkina Faso, South Africa and Mexico). Both
facilitators and barriers identified across the developing
country studies related not just to the supply of, but
also the demand for, evidence. This, again, emphasises
the importance of understanding policy processes in
context, and not assuming health policy will follow
when evidence is presented in a well-packaged format.
There is, not surprisingly, a general acceptance among
scholars and policy makers that research is not the sole
source of influence on policy change. Policy makers
have a wider context to consider and they have to
‘invariably take politics, not just data into account’ [41].
V i v i a nL i ni np a r t i c u l a rh a sd e f i n e dt h r e e‘competing
rationalities’ which policy makers must balance to make
decisions – technical, political, and cultural [14]. Policy
processes are always political, and vested interests can
have considerable effect over the scope to which it is
possible even for sympathetic policy makers to prioritise
issues or reform policy [8]. In the health sector, the
interests of various stakeholders such as politicians, pub-
lic servants, religious groups, pharmaceutical and diag-
nostic companies, and health professionals may often
run counter to the introduction of new research find-
ings, thus affecting policy making, budgeting, and imple-
mentation. Vested interests, combined with capacity
constraints, can hamper evidence-based reform of health
systems.
In terms of assessing research impact on policy, a
recent multi-sectoral review undertaken by Boaz and
colleagues found that most studies tend to adopt a case
study approach and utilise qualitative methods [12].
They also noted how such studies can be either forward
looking (tracking the contribution a specific research
project makes to policy or practice) or backward look-
i n g( f o c u s i n go nas p e c i f i cp o l i c yc h a n g ea n d
investigating which research evidence was used, and
how). However, the majority of impact assessment stu-
dies reveal that analysing attribution and impact of
research is certainly not an easy task, largely due to the
‘uncertainty in determining a causal link between
research and the outcome of a policy or the value of a
policy outcome’ [42]. Most studies make little attempt
to meaningfully deal with the issue of attribution
beyond key stakeholders’ perceptions. The challenge
here is while stakeholders may have unparalleled knowl-
edge of poorly-documented processes, they are also
likely to be biased. Triangulating data from different
stakeholders, and with whatever published and unpub-
lished documentary evidence is available, is therefore
important for verifying stakeholder perceptions. Further-
more, the timing of impact assessment is an issue as
there may be significant time lags to a policy change.
As Garrett notes, ‘the concrete results of policy
research… m a yt a k et i m et oe m e r g e ’, suggesting that
impact assessment takes place after some time lapse
[43]. However, policy engagement in public health is
often present at all stages of a research project, and it is
thus conceivable for some kinds of research impacts to
occur even while projects are ongoing.
An analytical framework for factors shaping research
impact on policy
Section 2 highlighted the complexity in defining
research impact, as well as the diversity in the range of
theories and approaches found in the literature to
explain policy change. In this section we synthesise key
elements from this literature that researchers can use to
understand their role in policy processes, and introduce
a framework to analyse the factors shaping the impact
of research on policy. Across multiple studies and sec-
tors – including efforts to synthesise what is known
about evidence use in development [6,29], or works
reviewing policy analysis theories in health [1,35], policy
change is seen to be driven by the interaction of three
dimensions, which can be combined to produce a synth-
esis approach:
1. Policy ideas/narratives – including how evidence
and the health issue are conceptualised, and the way
their relevance is understood with regard to policy
agendas.
2. Policy actors/networks – including work emphasis-
ing the importance of actor interests, key decision
makers and policy entrepreneurs, or networks and
groups who are influential in decision making.
3. Political context/institutions – including the ‘hard’
structures in which decisions are made, as well as the
broader ‘soft’ socio-economic, political and cultural
environments which shape policy processes (e.g. the for-
mal/informal ‘rules of the game’).
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influence each other. For example, the policy context
may influence which policy ideas are dominant and
affect the relationship between researchers and policy
actors. Research can affect or target each of the three
dimensions, but there are a number of factors mediating
its impact. Drawing on Jones and Sumner [44] and
Sumner and colleagues [45], it is possible to separate
these factors into two broad categories: first, those that
are given or pre-established in a policy arena, i.e. the
‘pre-conditions’ for research impact on policy; and sec-
ond, those related to researchers’‘ interventions’ for
research impact on policy.
The ‘pre-conditions’ for research impact on policy are
factors that are given in a particular policy arena or con-
text. These can include broad structural political con-
texts – such as the existence of responsive or
transparent governance mechanisms [46] – or more spe-
cific elements of the political system, such as the exis-
tence of national development strategies, levels of
decentralisation, or the roles played by civil society [47].
In contrast, researchers are also able to exert agency
over particular actions and strategies –‘ interventions’–
in order to increase the probability of research impact
in policy and practice throughout the research cycle.
Possible actions might include packaging the research to
have resonance with prevailing debates or increasing the
researcher’s involvement in policy and practice commu-
nities and networks. Researchers can also work towards
establishing a conducive environment in terms of orga-
nising regular meetings and consultations with key pol-
icy bodies. Table 1 summarises these pre-conditions for
research impact on policy and how researchers and
communications specialists can act or strategise within
these to support research to policy engagement.
Research impact in SRH policy and practice
The earlier sections of this paper highlighted a wide
range of concepts and theories that can provide insights
into research impact on policy. The field of SRH pro-
vides its own unique context in which those issues
might play out. SRH represents a health field with parti-
cularly strong interest group involvement. Decisions in
this field can also range from seemingly apolitical tech-
nical decisions around choice or timing of drug treat-
ments, to dramatically politicised debates around what
is considered sexually ‘normal’ or ‘acceptable’.I nt h i s
section we discuss how the synthesis developed above
may be applied to analysis of the factors affecting
research uptake in this specific field. In Additional file 1
we utilise the analytical framework we presented in
T a b l e1 ,i l l u s t r a t i n gh o wt h ef r a m e w o r kc a nb ea p p l i e d
to findings from many of the case studies in this supple-
ment (Additional file 1). As explained in Section 3, the
three dimensions of our framework (policy ideas, policy
actors/networks and policy context) can interrelate in
practice, and we draw out some of the examples of this
in our discussion of Additional file 1.
Policy Ideas/Narratives
The first section of our framework is concerned with
the pre-existing policy ideas, narratives and discourses
relating to the specific SRH issue, and the actions that
researchers can take to draw on or influence these ideas
and discourses. Both SRH and HIV/AIDS are primarily
considered health issues. As such, much of the discourse
and policy debate is framed within a public health para-
digm. Yet the nature of SRH and HIV/AIDS, however,
means that decisions made within these areas can often
have impacts on a range of other sectors and interest
groups. In particular, these issues touch on aspects of
sexuality, gender, and value judgements about beha-
vioural norms and ‘morality’ held by policy actors and
society at large. Some of the most obvious examples
would be decisions around abortion services, promotion
of different sexual behaviours (e.g. condom use) or non-
sexual behaviours (i.e. abstinence) for HIV prevention,
or engagement with individuals undertaking activities
that are criminalised in many countries (such as injec-
tion drug use or commercial sex). Sexuality and repro-
duction are core issues for groups concerned with
gender and human rights, and are often similarly impor-
tant for organised religious and civil rights groups. As
such, SRH policy issues may often serve as a point of
convergence, or indeed potential confrontation, between
actors and networks of actors from very different ideolo-
gical and disciplinary backgrounds.
In their paper, ‘Social Construction of Target Popula-
tions’, Anne Schneider and Helen Ingram argue that the
nature and social construction of target populations
have important implications for policy outcomes, such
as elements of the design or content [51]. By this they
mean the attribution of shared characteristics of a dis-
crete group, which have either positive or negative social
connotations. The groups include powerful, positively
constructed groups, labelled advantaged; powerful, nega-
tively constructed groups, labelled contenders; weak but
positively constructed groups, labelled dependents and
finally weak and negatively constructed groups, labelled
deviants. Users of SRH services in low income countries
often face significant difficulties in organising themselves
collectively to call for improvements in services (for a
discussion of this in relation to users of contraceptives,
see [52]), and tend to fall into either of the ‘weak’ cate-
gories. For example, pregnant women will often have
limited influence on policy, but are likely to be por-
trayed in a positive or deserving light, while groups such
as drug users, sex workers or men who have sex with
men are often labelled as deviants [53], reducing the
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ing the need for improved services for these groups.
However, framing the issue in a different way or show-
ing how it relates to existing national public health pol-
icy priorities may in some cases help to overcome
political reluctance to target services to marginalised
groups. For example, such a change occurred in Switzer-
land when provision of needles to injecting drug users
was reframed from a policy of drug maintenance to a
policy of harm reduction for HIV [54].
Additional file 1 shows some of the actions that
researchers can take in order to address prevailing nar-
ratives and discourses when communicating their
research. These include framing their research findings
in ways that resonate with popularly held ideas in order
to make the findings more attractive to policy makers.
Appealing to prevailing discourses may be more effec-
tive in cases where the issues at stake are neglected but
not too controversial [17,64]. They also include seeking
to change ideas and discourses which research evidence
shows to be harmful to health outcomes, for example by
changing the way policy makers think about margina-
lised groups. Additional file 1 presents examples of tak-
ing a longer-term approach to encouraging public
dialogue about sexuality in Bangladesh. Researchers
made use of the fact that academia is commonly viewed
by as having a high level of legitimacy in Bangladesh to
create spaces for challenging dominant societal values
[56].
The dominant public health paradigm that often
underlies SRH discussions derives from the disciplines
of medicine and epidemiology – both positivistic in out-
look. Therefore, the need to frame arguments and policy
recommendations as ‘evidence-based’ is typically pre-
sent. This can often be seen when actors from non-pub-
lic health backgrounds – such as advocacy groups, think
tanks, religious groups, or lobbyists – use this language
in making arguments. In another example in Additional
file 1, The Pleasure Project, an advocacy and research
organisation, carried out communications activities to
raise awareness among policy makers about the evi-
dence-base for the effectiveness of positive approaches
to promoting safe sex with the aim of incorporating
these approaches into mainstream HIV prevention [57].
Policy Actors/Networks
The second section of our framework focuses on the
policy actors who are target audiences for research. The
pre-existing characteristics of these target audiences
include their receptivity to the research evidence, and
the kinds of relationships and networks that researchers
can use in communicating their research. The evidence
generated by SRH research is varied, and different types
of evidence may be perceived in different ways by parti-
cular target audiences and intermediaries. Those trained
in health and other sciences typically adhere to a belief
in a hierarchy of evidence. ‘Hard’ evidence is that which
is seen as objective and quantitative. In contrast, ‘soft’
evidence is that which is subjective and qualitative [65].
Meta analyses of randomised controlled trials are at the
top of the hierarchy (with the RCT commonly referred
to as a ‘gold standard’ for evidence [66]), while anecdo-
tal evidence is at the bottom [67].
Many of those groups concerned with the social,
moral, and ideological issues touched upon by SRH may
not make decisions or draw conclusions in the same
way as the public health practitioners who attempt to
f o l l o wah i e r a r c h yo fe v i d e n c e( a sd e f i n e db yt h e i ro w n
discipline), yet the institutional context in which many
health decisions are made can often see that hierarchy
in operation, if only in the background. There are often
value judgements placed on evidence, or a need to
frame evidence in particular ways, in order to satisfy the
relevant decision makers. The context specificity, how-
ever, of many policies related to SRH – including nearly
all interventions dealing with social factors, sexual beha-
viour or health systems – has, as mentioned, led to
further concern regarding how to deal with so-called
‘complex interventions’ by public health practitioners
[68]. The fact that such situations are typically seen as
‘special cases’ again reiterates the dominant positivist
and causal paradigm that often exists in the health sec-
tor, as opposed to other social sciences which take such
complexity and need for evidence beyond experimental
t r i a l sa sas t a r t i n gp o i n t( e . g .[ 6 9 ] ) .T h en a t u r eo ft h e
policy change and proposed intervention can thus have
both political and complexity elements which need to
be considered when understanding the roles and relative
importance different types of evidence might play in
influencing policy decisions.
The strength of networks and relationships that
researchers can use to channel their research has a
strong impact on research uptake. Crichton and Theo-
bald show how pre-existing factors, such as the presence
or absence of institutional links between the research
institute and target policy actors, affect the ease of
access to policy makers. In addition, researchers take
action to create and strengthen relationships with policy
actors, through establishing partnerships and building
personal relationships [11]. For example, Additional file
1 provides examples of researchers and human rights
lawyers collaborating to create alliances with sympa-
thetic champions in government and civil society in
order to influence policy on services for survivors of
gender-based violence in Ghana (see also [58]). The
table also indicates cases where researchers have used
combinations of formal meetings and informal interac-
tions to build close working relationships with STI pol-
icy makers in Ghana [21] and journalists in Kenya [60].
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can help to facilitate communication on SRH issues
between policy makers and other groups in civil society.
For example, The Pleasure Project used research com-
munications activities to improve understanding
between public-health actors and the sex industry [57].
Policy Context/Institutions
Finally, Additional file 1 demonstrates some of the con-
textual issues that are important in research uptake in
the field of SRH. There is undoubtedly some SRH
research which is highly technical in nature, and for
which a policy change would have minimal moral impli-
cations – such as changing from one anti-retroviral drug
treatment regimen to another, or an alteration in health
worker responsibilities in the treatment of childbirth
complications. Yet this does not mean these will be com-
pletely apolitical decisions. As discussed above, politics
and vested interests have an important impact on health
policy making and may act as disincentives for evidence-
based policy. The nature of the particular SRH issue in
question and the political, economic and social implica-
t i o n so fp o l i c yc h a n g ei nt h a ta r e ah a v ei m p o r t a n ti n f l u -
ences on the responsiveness of policy audiences and the
‘room for manoeuvre’ policy makers have to use research
evidence [8]. For example, the size of a potential policy’s
impact, the types of people who would benefit or lose
from its introduction, and the social construction of the
issue and the target groups affected all affect research
uptake. Some research issues draw in an enormous range
of actors with competing interests and divergent attitudes
to issues such as sexuality and gender. In such cases, pol-
icy makers will face a range of what Lin has described as
‘competing rationalities’ [14]. An example of this would
be policies to provide adolescent girls with an HPV vac-
cine to prevent cervical cancer. While epidemiological
evidence exists on the incidence of cervical cancer, the
proportion linked to strains of HPV, and the efficacy of
the vaccine, the ultimate political decision will equally be
influenced by arguments around adolescent sexuality,
women’s and girls’ rights, and the role of the state around
those issues.
As aforementioned, contextual factors can interact
with the other dimensions of the framework. For exam-
ple, politics can influence the creation and propagation
of particular ideas or narratives that may be harmful to
health outcomes. In highly politically charged debates,
there are cases where some stakeholders may spread
incorrect information or even deliberate ‘misinforma-
tion’ about SRH issues. For example, on occasions when
groups have exaggerated the dangers of medical abor-
tion or overstated the side effects of contraceptives in
order to achieve their political or social aims. One note-
worthy example of this came in 2003 from a cardinal at
the Vatican, who wrote a report stating how latex
condoms may allow passage of particles larger than HIV
viruses, and that HIV increases with the numbers of
condoms distributed [70].
Additional file 1 gives some examples of the kinds of
approaches SRH researchers can use to address contex-
tual constraints to research uptake. In South Africa,
researchers addressed the suspicion and lack of under-
standing of research in their study communities by
using innovative consultation and communication tech-
niques in order to facilitate the transfer of research-
based knowledge to these communities (see also [63]).
Researchers can also use opportunities arising within
the policy process at specific points in time to influence
policy. Researchers in Zambia used the opportunity to
review draft national guidelines on ART therapy to
recommend that their research findings on cotrimoxa-
zole should be incorporated in Zambia’sn a t i o n a lH I V
treatment policy (see also [55]).
Conclusions
This paper reviewed the literatures on international
public health, policy analysis, and research impact eva-
luation to examine the uptake of evidence in the field of
sexual and reproductive health. However, collaborative
research projects involving public health researchers and
political scientists working on international development
or research impact evaluation remain relatively rare,
despite the scope for greater cross-fertilisation of con-
cepts, models and experience between them.
Review of existing work and analysis of the case stu-
dies in this supplement has highlighted how, when con-
sidering factors enabling research impact, it is helpful to
distinguish between those that are ‘pre-existing’ (part of
the policy context) and the actions and strategies (‘inter-
ventions’) deployed by researchers and communications
specialists. While the latter group are less focused on
more traditionally retrospective policy analysis, there are
increasing examples of frameworks and approaches
which take more prospective approaches, looking at
what researchers can do to improve the uptake of
research results (such as the Overseas Development
Institute’s RAPID programme, and much work by Lavis
and colleagues [5]). We argue that the second set of fac-
tors deserve increased attention from policy analysts,
not least because of their usefulness for future efforts to
influence policy with research. The analytical framework
introduced in this paper can be used by researchers to
examine the policy landscape affecting the uptake of
research in specific settings, in order to guide attempts
to ensure uptake of their findings. The case study papers
in this supplement contain both examples of research
on the use of evidence in policy making, as well as
examples exploring the roles played by researchers and
communications staff in influencing policy.
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